CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Net sales	$ 261,047	$ 242,274	$ 496,967	$ 482,000
Cost of products sold	170,887	167,531	329,585	318,227
Gross profit	90,160	74,743	167,382	163,773
Selling expenses	29,122	26,926	57,653	54,696
General and administrative expenses	36,386	23,363	67,129	49,810
Research and development expenses	4,781	6,102	9,602	12,268
Amortization of intangibles	7,683	7,547	15,318	15,047
Operating expenses	77,972	63,938	149,702	131,821
Income from operations	12,188	10,805	17,680	31,952
Interest and debt expense	8,747	8,352	17,445	16,587
Investment (income) loss	(521)	(610)	(1,570)	(819)
Foreign currency exchange (gain) loss	754	(792)	412	(398)
Other (income) expense, net	59	23,806	(118)	24,484
Income (loss) before income tax expense (benefit)	3,149	(19,951)	1,511	(7,902)
Income tax expense (benefit)	(1,446)	(4,908)	(1,186)	(1,488)
Net income (loss)	$ 4,595	$ (15,043)	$ 2,697	$ (6,414)
Average basic shares outstanding (in shares)	28,726	28,869	28,692	28,852
Average diluted shares outstanding (in shares)	28,874	28,869	28,841	28,852
Basic income (loss) per share (in dollars per share)	$ 0.16	$ (0.52)	$ 0.09	$ (0.22)
Diluted income (loss) per share (in dollars per share)	0.16	(0.52)	0.09	(0.22)
Dividends declared per common share (in dollars per share)	$ 0.07	$ 0.07	$ 0.07	$ 0.07